发明名称 |
USE OF A COMBINATION OF AMOXYCILLIN AND CLAVULANATE IN THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT DRUG-RESISTANT STREPTOCOCCUS PNEUMONIA |
摘要 |
Infections potentially caused by DRSP may be treated by a method which comprises administering a pharmaceutical formulation comprising either: for an adult or older child patient from 800 to 1100 mg amoxycillin and from 100 to 150 mg clavulanate in a weight ratio between 6:1 and 10:1 inclusive; or for a paediatric patient from 30 to 40 mg/kg body weight of amoxycillin and from 3 to 8 mg/kg body weight of clavulanate in a weight ratio between 6:1 and 10:1 inclusive; in combination with a pharmaceutically acceptable carrier or excipient, three times a day (tid).
|
申请公布号 |
WO9807424(A1) |
申请公布日期 |
1998.02.26 |
申请号 |
WO1997GB02235 |
申请日期 |
1997.08.19 |
申请人 |
SMITHKLINE BEECHAM PLC;BAX, RICHARD, PEREGRINE |
发明人 |
BAX, RICHARD, PEREGRINE |
分类号 |
A61K31/424;A61K31/43;A61P31/04;(IPC1-7):A61K31/43 |
主分类号 |
A61K31/424 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|